Chemokines: established and novel targets in atherosclerosis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Chemokines: established and novel targets in atherosclerosis

Published:2011-10-28 Issue:12 Volume:3 Page:713-725
ISSN:1757-4676
Container-title:EMBO Molecular Medicine
language:en
Short-container-title:EMBO Mol Med

Author:

Koenen Rory R.¹²,Weber Christian¹²³

Affiliation:

1. Institute for Cardiovascular Prevention, Ludwig‐Maximilians‐University of Munich, Munich, Germany

2. Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, Maastricht, The Netherlands

3. Munich Heart Alliance, Munich, Germany

Publisher

EMBO

Subject

Molecular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/emmm.201100183

Reference108 articles.

1. CCR2 receptor blockade alters blood monocyte subpopulations but does not affect atherosclerotic lesions in apoE−/− mice

2. Natural regulatory T cells control the development of atherosclerosis in mice

3. The Chemokine RANTES Is a Crucial Mediator of the Progression from Acute to Chronic Colitis in the Rat

4. Therapy with Nonglycosaminoglycan-Binding Mutant CCL7: A Novel Strategy to Limit Allograft Inflammation

5. Targeted Disruption of the Scavenger Receptor and Chemokine CXCL16 Accelerates Atherosclerosis

Cited by 91 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cardiovascular disease and thrombosis: Intersections with the immune system, inflammation, and the coagulation system;Annales Pharmaceutiques Françaises;2024-08

2. Human Plaque Myofibroblasts to Study Mechanisms of Atherosclerosis;Journal of the American Heart Association;2023-11-07

3. Assessment of Circulating CCR6 Level in Acute Myocardial Infarction and its Association with Disease Severity;Cardiovascular & Hematological Agents in Medicinal Chemistry;2023-11

4. The Crossroads of the Coagulation System and the Immune System: Interactions and Connections;International Journal of Molecular Sciences;2023-08-08

5. Sirt4 deficiency promotes the development of atherosclerosis by activating the NF-κB/IκB/CXCL2/3 pathway;Atherosclerosis;2023-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3